Skip to main content

Table 1 Baseline demographic and clinical characteristics of the patients

From: Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia

 

ITT

PP

 

Triple therapy

Sequential therapy

Triple therapy

Sequential therapy

Number of patients

44

364

40

345

Age (Mean ± SD)

52.6 ± 9.5

51.0 ± 11.2

53.7 ± 9.0

51.1 ± 11.2

Gender (%)

    

 Male

9 (20.5 %)

135 (37.1 %)

7 (17.5 %)

127 (36.8 %)

 Female

35 (79.5 %)

229 (62.9 %)

33 (82.5 %)

218 (63.2 %)

Endoscopic finding

    

iDU

44 (100 %)

126 (34.6 %)

  

NUD

 

238 (65.4 %)

  

Eradication success

34

304

34

304

Eradication rate

77.3 %

83.5 %

85.0 %

88.1 %

 95 % CI

64.9–89.7 %

79.9–87.3 %

73.9–96.1 %

84.7–91.5 %

 P-value

0.29

0.57

  1. ITT intention to treat, PP per protocol